Epson has announced that it will apply and use its patented Dry Fibre technology, the same technology it uses within its unique PaperLab A-8000 system, to now start producing face masks for its employees.
The masks that Epson will now manufacture respond to growing demand for face masks for protection against the novel coronavirus (COVID-19).
Epson’s PaperLab A-8000 in-office dry paper making system, is a dry-process* technology that enables the processing and creation of paper on-site, in the amount you need and when you need it. In the case of the new masks, they will be made not from used paper but from functional fibres and will be manufactured at two of Epson’s production plants. This in turn will eliminate the need for Epson to outsource purchasing masks for its employees.
As well as manufacturing the masks in-house for its employees, Epson will also donate 100,000 masks to local authorities and medical institutions where needs for personal protective equipment (PPE) have been expanding. The company will also donate 5,600 face shields to the same organisations.
Epson does not plan to sell the masks it manufactures commercially.
Epson often makes significant and regular contributions to realising a sustainable society and has made a commitment to ongoing efforts that realise the United Nations' Sustainable Development Goals.
For more information on PaperLab and Dry Fibre technology go to:
https://global.epson.com/innovation/paperlab/
